AsiaNet Daily Summary - Press Releases for Thursday, July 17, 2008

SYDNEY--18 Jul--AsiaNet/InfoQuest


BINDING DEAL...

TOKYO and NEW DELHI: Following intense speculation in sections of the media

and the stock market, Daiichi Sankyo Company, Limited  and Ranbaxy Laboratories
Limited reiterate that the agreement between Daiichi Sankyo, Ranbaxy and the
Singh family, the largest controlling shareholders of Ranbaxy, is binding and
final, subject to regulatory approvals.
www.daiichisankyo.com

SURVEY FINDINGS...

PHILADELPHIA and LONDON: The Scientific business of Thomson Reuters Thursday

announced the early findings of its 2008 Liquent Regulatory Affairs Trends
Survey.
http://www.thomsonreuters.com
http://www.liquent.com/2008survey
http://www.thomsonreuters.com/products_services/scientific1/liquentinsight

SAFETY RECALL...

SYDNEY: LG Electronics is voluntarily recalling selected microwave ovens

manufactured between August 2007 to February 2008 in order to repair a fault
which may pose a risk of electric shock to the user.

OFFER PRICE...

MUMBAI: BASF SE Thursday announced that it has revised its offer price for

shares in BASF India, to Rs. 300 per share.
http://www.basf.com

JAPAN APPROVES...

LAUSANNE: Galderma Pharma S.A., a global specialty pharmaceutical company

focused on dermatology, announced Thursday that Japan's Ministry of Health,
Labor and Welfare has approved Differin Gel 0.1% (adapalene), a novel topical
treatment for acne vulgaris in Japan.
http://www.galderma.com

PALOMAR ESTABLISHES...

BURLINGTON, Mass.: Palomar Medical Technologies, Inc., a leading researcher

and developer of light-based systems for cosmetic treatments, Thursday
announced the establishment of an international sales office in Australia to
support Palomar's efforts in gaining market share and assist with sales,
service and marketing in Australia and New Zealand.
http://www.prnewswire.com/comp/107555.html
http://www.palomarmedical.com

INTERNATIONAL KEYBOARDS...

JACKSONVILLE: Seal Shield LLC has begun shipping a new family of fully

submersible, 108 key, International keyboards with SILVER SEAL Antimicrobial
protection to help reduce the risk of worldwide cross contaminations, including
Norovirus and the "superbug," MRSA.
http://www.sealshield.com

EXCLUSIVE REPRESENTATION...

LOS ANGELES: Luxe Worldwide Hotels, the leading provider of full-service

representation services within the international hotel industry, Thursday
announced its exclusive representation of New World Hotel Management Ltd.
http://www.luxehotels.com
http://www.newworldhotels.com

GLOBAL DIALOGUE...

MADRID: A World Conference on Dialogue will held From the 16 to 18 of July,

2008 in Madrid by an invitation from King Abdullah bin Abdulaziz Al-Saud of
Saudi Arabia.
http://www.world-dialogue.org

PHARMA EVENTS...

LONDON: CMPi events for the fast-developing pharma markets of South and

Latin America debut next month. Rio de Janeiro will host the twin launch of the
CPhI South America pharma ingredients and P-MEC South America pharma machinery
and equipment exhibitions on Tuesday 19 - Thursday 21 August. Sao Paulo will
then host the 2009 events.
http://www.cmpi.biz

SUPPLY AGREEMENT...

ROBBINSVILLE, N.J.: EPV SOLAR, Inc. a thin-film solar module manufacturer

and photovoltaic systems provider headquartered in New Jersey, USA, announced
Wednesday that it has entered into a long-term solar module supply agreement
with City Solar Kraftwerke AG.
http://www.epvsolar.com
http://www.citysolar.de

KEYNOTE ADDRESS...

LONDON: The Rt Hon Hazel Blears MP, Secretary of State for Communities and

Local Government will present the closing keynote address at the annual Fire &
Rescue Conference on 28 August 2008 at the newly built Arena and Convention
Centre (ACC) in Liverpool.
http://www.fireandrescueexpo.com

JEWELLERY FAIR...

HYDERABAD: The Hyderabad Jewellery, Pearl & Gem Fair 08,(HJF), the largest

international jewellery fair in South India, will be held from 24th to 27th
July, 2008 at the HITEX Exhibition Centre.

AERCAP ANNOUNCES...

AMSTERDAM, and MIAMI: AerCap Holdings N.V. Wednesday announced that it has

successfully completed its planned management transition at its AeroTurbine
subsidiary.

COLLABORATION AGREEMENT...

NOVATO, Calif.: Raptor Pharmaceuticals Corp. Wednesday announced the

execution of a collaboration agreement with the University of California, San
Diego (UCSD) to include a Phase 2a clinical trial to evaluate a delayed-release
preparation of cysteamine bitartrate in adolescents diagnosed with
Non-Alcoholic Steatohepatitis (NASH).
http://www.raptorpharma.com

COMPLEGENT TECHNOLOGY...

PRINCETON, N.J.: BioWa, Inc. and Medarex, Inc. Wednesday announced that they

have entered into a license agreement which provides Medarex with the first
ever access to BioWa's COMPLEGENT Technology for enhancing the
complement-dependent cytotoxicity (CDC) of select Medarex therapeutic
antibodies.
http://www.biowa.com
http://www.medarex.com

MOBILE ACCESS...

SHANGHAI: Millions of viewers worldwide will stay abreast of live sports

coverage this summer with TV handsets that incorporate Telegent's free-to-air
mobile TV technology.
http://www.telegent.com

AsiaNet is a consortium of leading news agencies distributing unedited,

translated news releases for worldwide clients. Visit www.asianetnews.net for
full-text versions.

ข่าวDaiichi Sankyo Company+Daiichi Sankyo Coวันนี้

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

CMC Biologics today announced the execution of an agreement with Daiichi Sankyo Co., Ltd. ('Daiichi Sankyo') to provide process development support and manufacture of several clinical-stage antibodies over a three-year period. The two companies have recently begun work on their first joint project at CMC Biologics' Bothell manufacturing facility. Specific terms of the agreement were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO ) "CMC Biologics is delighted to

U.S. Regulators Approve Prasugrel for Reduction of Cardiovascular Events In Patients with Acute Coronary Syndromes Managed with Artery-Opening Procedure

Daiichi Sankyo Company, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved Effient...

World Heart Federation, Daiichi Sankyo and Lilly Partner to Improve Cardiovascular Health

The World Heart Federation, Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) announced today that they have partnered to improve cardiovascular health internationally. The...

European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

Heart patients with acute coronary syndrome (ACS) undergoing an artery-opening procedure will soon have a new treatment option to help prevent heart attacks. Daiichi Sankyo Company, Limited ...

Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee

The U.S. Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee voted 9 to 0 that prasugrel, an investigational antiplatelet agent, should be approved for the treatment of patients with acute...

สรุปข่าวเอเชียเน็ทประจำวันพฤหัสบดีที่ 17 กรกฎาคม 2551

ข้อตกลง โตเกียวและนิวเดลี: หลังจากที่มีการคาดการณ์กันมากในส่วนของสื่อมวลชนและตลาดหุ้น ไดอิจิ ซังเคียว จำกัด (Daiichi Sankyo Company, Limited) และ แรนแบ็กซี่ ลาบอราทอรีส์ จำกัด (Ranbaxy Laboratories Limited) ได้ตอกย้ำถึงข้อตกลงระหว่างกัน ...

AsiaNet Daily Summary - Press Releases for Thursday, July 17, 2008

BINDING DEAL... TOKYO and NEW DELHI: Following intense speculation in sections of the media and the stock market, Daiichi Sankyo Company, Limited and Ranbaxy Laboratories Limited reiterate that the agreement between Daiichi Sankyo,...

แรนแบ็กซี่ เตรียมดึง ไดอิจิ ซังเคียว เข้าถือหุ้นใหญ่ในบริษัท หวังขึ้นแท่นบริษัทเวชภัณฑ์ยักษ์ใหญ่ของโลก

บริษัท ไดอิจิ ซังเคียว จำกัด (Daiichi Sankyo Company, Limited) (TSE: 4568.JP) บริษัทเวชภัณฑ์รายใหญ่ที่สุดแห่งหนึ่งของญี่ปุ่น และ แรนแบ็กซี่ ลาบอราทอรีส์ จำกัด (Ranbaxy Laboratories Limited) (NSE/BSE...

Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse

Daiichi Sankyo Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo"), one of the largest pharmaceutical companies in Japan, and Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy...

แรนแบ็กซี่ประกาศปรับปรุงมาตรฐานทางธุรกิจและการประกันคุณภาพ

บริษัท แรนแบ็กซี่ ลาบอราทอรีส์ จำกัด (Ranbaxy Laboratories Limited) (จากนี้ไปจะเรียกว่า แรนแบ็กซี่) ซึ่งเป็นบริษัทสาขาในเครือของบริษัทไดอิจิ ซังเคียว จำกัด (Daiichi Sankyo Co., Ltd.) (จากนี้ไปจะเรียกว่า ไดอิจิ ซังเคียว) ประกาศในวันที่ 22...